Continues the study of rational drug therapy and therapeutic approaches for major diseases, with emphasis on treatment selection, monitoring and patient care.
Course Outcome:
CO1: Apply rational antibiotic use guidelines and understand pharmacotherapy for infectious diseases including tuberculosis, meningitis, respiratory tract infections, gastroenteritis, endocarditis, septicemia, urinary tract infections, malaria, HIV and opportunistic infections, fungal and viral infections, gonorrhea, and syphilis.
CO2: Understand the pathophysiology and pharmacological management of musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, gout, spondylitis, and systemic lupus erythematosus.
CO3: Describe the clinical features and pharmacotherapy of renal disorders including acute and chronic renal failure, renal dialysis, and drug-induced renal disorders.
CO4: Comprehend the basic principles of cancer therapy, including the mechanisms, indications, and management of chemotherapy for breast cancer and leukemia, as well as supportive care for chemotherapy-induced nausea and emesis.
CO5: Understand common dermatological conditions such as psoriasis, scabies, eczema, and impetigo, and apply appropriate pharmacotherapeutic interventions.